Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
Summit History
20th Bioshares Biotech Summit
Contact
Contact Us
Email Alerts
Home
>
Premium Biotech Coverage
>
Current News
Current News
Categories
Categories
Acrux
Actinogen (ACW)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Cynata Therapeutics
Dimerix (DXB)
Imugene (IMU)
Neuren Pharmaceuticals (NEU)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
August 24th, 2026
BlinkLab Delivers Very Good Results in Second Indication, ADHD
Read More
August 24th, 2026
‘Landmark Year’ for Cogstate
Read More
August 24th, 2026
Neuren Pharmaceuticals - DAYBUE Sales Growth Stuns Market
Read More
July 14th, 2026
Imugene to Raise $11 Million in Placement and Looks for Licensing Deal
Read More
July 14th, 2026
Cogstate - Record Sales for FY2026
Read More
July 14th, 2026
Syntara's Compound Records Some Activity in Prodromal Parkinson's Disease
Read More
July 14th, 2026
Neuren - CHMP Reverses View on DAYBU in Europe
Read More
June 22nd, 2026
Steady Adoption by Big Pharma Continues for Clever Culture Systems
Read More
June 22nd, 2026
Double Negative for Cynata Therapeutics
Read More
June 22nd, 2026
Dimerix Secures Fifth International Licensing Deal
Read More
Pages
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
